Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are ...

Black Americans have double the risk of developing multiple myeloma compared to white Americans and are diagnosed at younger ...

New cell therapy, Cilta-cel, shows promise in the treatment of multiple myeloma, providing a personalised approach with the ...

Traditionally carrying a dire prognosis, the treatment paradigm for multiple myeloma is changing, with CAR T therapies, ...

The following is a summary of “Time-dependent recovery of renal impairment in patients with newly diagnosed multiple myeloma, ...

Advertisements International Myeloma Foundation (IMF) to Hold Miracles for Myeloma Virtual/In-Person 5K Run/Walk in Boca Raton, FL Advertisements Boca Raton, FL – This March, in honor of Myeloma ...

Recovery from multiple myeloma leads to a renewed sense of purpose and determination, with hope found in small victories. The ...

For patients with newly diagnosed multiple myeloma (NDMM) receiving dexamethasone induction, dose reductions do not ...

The researchers also projected that newly diagnosed MM cases will increase by 70.8% by 2045 — from about 188,000 cases in 2022 to about 321,000 cases in 2045. The number of deaths due to MM is ...

A new editorial was published in Oncoscience's Volume 12 on January 14, 2025, titled "Pomalidomide improved immune profiles in myeloma." ...

Bispecific antibody therapy is transforming cancer treatment, especially in multiple myeloma, with ongoing studies exploring ...

Myeloma, also known as multiple myeloma, is a type of blood cancer that starts in plasma cells, an important part of the immune system. These abnormal plasma ce ...